Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
21.27
+0.82 (4.01%)
At close: Feb 21, 2025, 4:00 PM
21.35
+0.08 (0.38%)
After-hours: Feb 21, 2025, 7:49 PM EST
Immunovant Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Immunovant stock have an average target of 45.9, with a low estimate of 36 and a high estimate of 53. The average target predicts an increase of 115.80% from the current stock price of 21.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunovant stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 5 | 6 |
| Buy | 5 | 6 | 5 | 6 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $46 → $44 | Strong Buy | Maintains | $46 → $44 | +106.86% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +139.77% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +139.77% | Feb 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $48 → $45 | Strong Buy | Maintains | $48 → $45 | +111.57% | Jan 15, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 3, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
7.03M
EPS This Year
-2.87
from -1.88
EPS Next Year
-3.08
from -2.87
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 65.1M | 150.2M | ||
| Avg | n/a | 7.0M | 48.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 2,036.8% | ||
| Avg | - | - | 590.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.28 | -2.34 | -1.50 | ||
| Avg | -2.87 | -3.08 | -3.08 | ||
| Low | -3.03 | -3.52 | -3.77 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.